FIELD: pharmaceuticals.
SUBSTANCE: new compounds of Formula (I) based on pyrazolopyridinone and pharmaceutical compositions containing these compounds.
(I)
EFFECT: new compounds have been obtained that have inhibitory activity against FGFR (fibroblast growth factor receptor).
24 cl, 2 tbl, 15 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOUNDS BASED ON PYRAZOLOPYRIDINONE | 2018 |
|
RU2806751C2 |
NEW QUINOLINE COMPOUNDS | 2018 |
|
RU2810113C2 |
NEW COMPOUNDS | 2013 |
|
RU2654857C2 |
PTERIDINES AS FGFR INHIBITORS | 2013 |
|
RU2702906C2 |
IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES | 2009 |
|
RU2518089C2 |
ANTI-CANCER BENZOPYRAZINES ACTING THROUGH FGFR-KINASES INHIBITION | 2012 |
|
RU2639863C2 |
DERIVATIVES OF 1,5- AND 1,7-NAPHTHYRIDINE USEFUL IN TREATMENT OF FGFR-MEDIATED DISEASES | 2012 |
|
RU2629194C2 |
NEW COMPOUNDS | 2016 |
|
RU2747645C2 |
QUINOLINES AS FGFR KINASE MODULATORS | 2012 |
|
RU2625303C2 |
SUBSTITUTED QUINAZINE DERIVATIVES AS FGFR-KINASE INHIBITORS FOR TREATMENT OF CANCER | 2011 |
|
RU2602233C2 |
Authors
Dates
2023-11-02—Published
2018-11-23—Filed